Showing results (91-100 of 121) with videos related to
Sort By:
Pageof 13
Annals of Medicine and Surgery (2012)|January 19, 2016
Anti-inflammatory liposomes have no impact on liver regeneration in ratsBetina Norman Jepsen, Kasper Jarlhelt Andersen, Anders Riegels Knudsen, et al.Scientific Reports|December 2, 2024
Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformationMarie Hairing Enemark, Katharina Wolter, Trine Engelbrecht Hybel, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 8, 2023
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole bloodLene Ugilt Pagter Ludvigsen, Annemette Sloth Andersen, Stephen Hamilton-Dutoit, et al.Journal of the National Cancer Institute|February 18, 2011
CYP2D6 inhibition and breast cancer recurrence in a population-based study in DenmarkTimothy L Lash, Deirdre Cronin-Fenton, Thomas P Ahern, et al.Pharmacoepidemiology and Drug Safety|May 14, 2025
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling ApproachKirsten M Woolpert, Deirdre P Cronin-Fenton, Per Damkier, et al.British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.Pageof 13